Historical record - last NADAC effective date: 1/1/2018
Product Information
CYTOMEL 50 MCG TABLET is a brand product labeled by Pfizer Inc., priced at $3.7012 per EA under NDC 60793011701. Its NADAC has been published 251 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the liothyronine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 ug/1
Manufacturer
Pfizer Inc.NDC
60793011701
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2018
Active Ingredients
LIOTHYRONINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA010379FDA Approved
Before 1982
TE Code
AB
On Market Since
5/8/1956
Pharmacological Classes
Price Statistics
The NADAC for CYTOMEL 50 MCG TABLET has been published 251 times since Nov 28, 2013, and over the history we have for it it has risen 91.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7012 per EA |
|---|---|
| All-time high | $3.7012 (Jan 16, 2019) |
| All-time low | $1.8889 (Apr 23, 2014) |
| Median price | $2.8236 |
| Average price | $2.8389 |
| Largest weekly change | +9.4% (Jan 6, 2016) |
| Weeks tracked | 251 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+91.6%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYTOMEL 50 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYTOMEL 50 MCG TABLET, manufactured by Pfizer Inc., is $3.7012 per EA (NDC 60793011701), effective Jan 16, 2019.
How has the price of CYTOMEL 50 MCG TABLET changed over time?
Over the history we have for it, the NADAC for CYTOMEL 50 MCG TABLET has risen 91.6%. It has been tracked across 251 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYTOMEL 50 MCG TABLET?
Since Nov 28, 2013, the NADAC for CYTOMEL 50 MCG TABLET has ranged from a low of $1.8889 (Apr 23, 2014) to a high of $3.7012 (Jan 16, 2019), with a median of $2.8236 per EA.
Are there cheaper alternatives to CYTOMEL 50 MCG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIOTHYRONINE SOD 50 MCG TAB, is $0.3729 per EA — about 90% below CYTOMEL 50 MCG TABLET.
Who manufactures CYTOMEL 50 MCG TABLET?
CYTOMEL 50 MCG TABLET (NDC 60793011701) is labeled by Pfizer Inc., and CMS classifies it as a brand product.